Browse 51 myasthenia gravis clinical trials enrolling across the United States and Canada. Search by city or state to find one near you.
Myasthenia gravis causes muscle weakness that gets worse with use and improves with rest, often starting with a drooping eyelid or double vision. For decades treatment relied mainly on steroids and broad immune suppression, with side effects that can be hard to live with. In recent years several new targeted medicines have been approved that act directly on the antibodies behind the disease.
